BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9816705)

  • 1. Trypanocidal effect of SKF525A, proadifen, on different developmental forms of Trypanosoma cruzi.
    Franke De Cazzulo BM; Bernacchi A; Esteva MI; Ruiz AM; Castro JA; Cazzulo JJ
    Medicina (B Aires); 1998; 58(4):415-8. PubMed ID: 9816705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypanocidal action of 2,4-dichloro-6-phenylphenoxyethyl diethylamine hydrobromide (Lilly 18947) on Trypanosoma cruzi.
    Bernacchi AS; Franke De Cazzulo B; Castro JA
    Acta Pharmacol Sin; 2002 May; 23(5):399-404. PubMed ID: 11978189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Trypanosoma cruzi effects of cyclosporin A derivatives: possible role of a P-glycoprotein and parasite cyclophilins.
    Búa J; Fichera LE; Fuchs AG; Potenza M; Dubin M; Wenger RO; Moretti G; Scabone CM; Ruiz AM
    Parasitology; 2008 Feb; 135(2):217-28. PubMed ID: 17922928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanocidal effects of promethazine.
    Fernández AR; Fretes R; Rubiales S; Lacuara JL; Paglini-Oliva P
    Medicina (B Aires); 1997; 57(1):59-63. PubMed ID: 9435371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoxazolylnaphthoquinone effects on the growth of Trypanosoma cruzi.
    Amuchástegui PI; Moretti ER; Basso B; Sperandeo N; de Bertorello MM
    Rev Argent Microbiol; 1990; 22(4):199-207. PubMed ID: 2129475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neolignans from plants in northeastern Brazil (Lauraceae) with activity against Trypanosoma cruzi.
    Cabral MM; Barbosa-Filho JM; Maia GL; Chaves MC; Braga MV; De Souza W; Soares RO
    Exp Parasitol; 2010 Mar; 124(3):319-24. PubMed ID: 19944690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of placental subfractions on Trypanosoma cruzi.
    Frank F; Sartori MJ; Asteggiano C; Lin S; de Fabro SP; Fretes RE
    Exp Mol Pathol; 2000 Oct; 69(2):144-51. PubMed ID: 11001862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of lytic peptides against intracellular Trypanosoma cruzi amastigotes in vitro and parasitemias in mice.
    Barr SC; Rose D; Jaynes JM
    J Parasitol; 1995 Dec; 81(6):974-8. PubMed ID: 8544074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of in vitro and in vivo trypanocidal properties of a new imidazole-containing nitrophthalazine derivative.
    Olmo F; Gómez-Contreras F; Navarro P; Marín C; Yunta MJ; Cano C; Campayo L; Martín-Oliva D; Rosales MJ; Sánchez-Moreno M
    Eur J Med Chem; 2015 Dec; 106():106-19. PubMed ID: 26523668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanosoma cruzi: in vitro activity of Epoxy-alpha-Lap, a derivative of alpha-lapachone, on trypomastigote and amastigote forms.
    Bourguignon SC; Castro HC; Santos DO; Alves CR; Ferreira VF; Gama IL; Silva FC; Seguins WS; Pinho RT
    Exp Parasitol; 2009 Jun; 122(2):91-6. PubMed ID: 19285074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trypanosoma cruzi: effect of protein kinase inhibitors and cytoskeletal protein organization and expression on host cell invasion by amastigotes and metacyclic trypomastigotes.
    Procópio DO; da Silva S; Cunningham CC; Mortara RA
    Exp Parasitol; 1998 Sep; 90(1):1-13. PubMed ID: 9709024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanosoma cruzi: activity of heterocyclic cationic molecules in vitro.
    Pacheco MG; da Silva CF; de Souza EM; Batista MM; da Silva PB; Kumar A; Stephens CE; Boykin DW; Soeiro Mde N
    Exp Parasitol; 2009 Sep; 123(1):73-80. PubMed ID: 19520077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro effects of suramin on Trypanosoma cruzi.
    Bisaggio DF; Adade CM; Souto-Padrón T
    Int J Antimicrob Agents; 2008 Mar; 31(3):282-6. PubMed ID: 18191547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trypanosoma cruzi: trypanocidal effect of 2(3)-tert-butyl-4-hydroxyanisole (BHA) on several strains of epimastigote and trypomastigote forms.
    Aldunate J; Ojeda JM; Repetto Y; Letelier ME; Spencer P
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1994 Oct; 109(2):119-27. PubMed ID: 7881815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological aspects of the Trypanosoma cruzi (Dm28c clone) intermediate form, between epimastigote and trypomastigote, obtained in modified liver infusion tryptose (LIT) medium.
    Bourguignon SC; Mello CB; Santos DO; Gonzalez MS; Souto-Padron T
    Acta Trop; 2006 Apr; 98(1):103-9. PubMed ID: 16574051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trypanosoma cruzi: in vitro and in vivo antiproliferative effects of epigallocatechin gallate (EGCg).
    Güida MC; Esteva MI; Camino A; Flawiá MM; Torres HN; Paveto C
    Exp Parasitol; 2007 Oct; 117(2):188-94. PubMed ID: 17673202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleomorphism in trypomastigotes of Trypanosoma cruzi from blood and cell culture.
    Urdaneta-Morales S
    Tropenmed Parasitol; 1983 Dec; 34(4):225-8. PubMed ID: 6420964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The trypanocidal effect of sesquiterpene lactones helenalin and mexicanin on cultured epimastigotes.
    Jimenez-Ortiz V; Brengio SD; Giordano O; Tonn C; Sánchez M; Burgos MH; Sosa MA
    J Parasitol; 2005 Feb; 91(1):170-4. PubMed ID: 15856894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trypanosoma cruzi: Biological characterization of lineages I and II supports the predominance of lineage I in Colombia.
    Mejía-Jaramillo AM; Peña VH; Triana-Chávez O
    Exp Parasitol; 2009 Jan; 121(1):83-91. PubMed ID: 18950627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro anti-parasitic activity of Cyclosporin A analogs on Trypanosoma cruzi.
    Búa J; Ruiz AM; Potenza M; Fichera LE
    Bioorg Med Chem Lett; 2004 Sep; 14(18):4633-7. PubMed ID: 15324878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.